Recently, it was reported that cell death caused by a PI3K inhibitor, BKM-120, was associated with TP53 status in glioma cells [48], and that PI3K/AKT inhibition was suggested to induce TP53-dependent apoptosis in HTLV-1-transformed cells [49]. Here, TP53 is linked to central nervous system cancer.